Document is current
Any future updates will be listed below
-
Authors
Azar, Chris
Barboi, Cristina https://orcid.org/0000-0002-8356-7285
Perkins, Anthony
Ortiz, Damaris
Zarzaur, Ben L.
Alhader, Abdelfattah
Boustani, Malaz A.
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG052493)
- License Information
-
More Information
Article History
Received: 1 March 2025
Accepted: 12 November 2025
First Online: 25 November 2025
Declarations
:
: The Indiana University Institutional Review Board approved the study (IRB #1612690852).
: N/A.
: Dr. Boustani serves as a chief scientific officer and co-founder of BlueAgilis; the chief health officer of DigiCare Realized, Inc.; and the chief health officer of Mozyne Health, Inc. He has an equity interest in Blue Agilis, Inc.; DigiCare Realized, Inc.; and Mozyne Health, Inc. He sold his equity in Preferred Population Health Management LLC and MyShift, Inc. (formerly RestUp, LLC). He serves as an advisory board member or consultant for Eli Lilly and Co., Eisai, Inc., Merck & Co., Inc., Biogen Inc., and Genentech Inc. Indiana University has reviewed these conflicts and have been appropriately managed to maintain objectivity.
